Happy New Year from Nexus Corporate Finance!
Following from our 2016 M&A round-up the below provides further detail on December 2016's deal activity. This month's Last Word is by Dr Gordon Hamilton, Managing Director of Nexus Corporate Finance.
For day-to-day updates in the UK Healthcare and Education sector, follow us on twitter @Nexus_CF
This month's Last Word is by Dr Gordon Hamilton, Managing Director of Nexus Corporate Finance.
" Forgive my indulgence, but 2016 finished on a high for me after successfully advising the shareholders of Rapidscan Pharma Solutions on their sale to GE Healthcare. The deal was more than the usual cross border rollercoaster deal concerning the commercialisation of a complex intellectual property asset played out over fifteen months with robust negotiations, but when all is said and done the transaction represents an excellent deal for both sides. The international roll-out of Rapidscan’s market leading product is accelerated by a partner with a huge geographic footprint as well as significant resources and expertise in diagnostic imaging in acute hospitals.
Is there are read through to the wider Healthcare market? Yes - if M&A is the right strategy for a business to reach its full potential, it doesn’t really matter what wider geopolitical uncertainties arise be it Trump or Brexit.
Here's looking to a great 2017! "